Renal failure associated with a specific inhibitor of BCR‐ABL tyrosine kinase, STI 571
Author:
Publisher
Oxford University Press (OUP)
Subject
Transplantation,Nephrology
Link
http://academic.oup.com/ndt/article-pdf/17/4/685/23372340/170685.pdf
Reference7 articles.
1. Goldman JM, Melo JV. Targeting the BCR‐ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med2001; 344: 1084–1086
2. Druker BJ, Sawyers CL, Kantarjian H et al. Activity of a specific inhibitor of the BCR‐ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med2001; 344: 1038–1042
3. Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the BCR‐ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med2001; 344: 1031–1037
4. Smith GA, Damon LE, Rugo HS et al. High‐dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency. J Clin Oncol1997; 15: 833–839
5. Tanaka M, Kanamori H, Yamaji S et al. Low‐dose cytarabine‐induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome. Anticancer Drugs1999; 10: 289–291
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review;European Journal of Haematology;2022-05-24
2. Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction;Clinical Case Reports;2021-08
3. Successful Treatment of End-stage Renal Disease in a Patient With Chronic Myeloid Leukemia by Kidney Transplantation and Tyrosine Kinase Inhibitors: A Case Report;Transplantation Proceedings;2020-03
4. Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence;Kidney International;2019-09
5. Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias;Clinical Lymphoma Myeloma and Leukemia;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3